BACKGROUND: Multidrug resistance related proteins (MRP-proteins), members of the ATP binding cassette (ABC-) superfamily, are known to play an important role in regulation of glutathione homeostasis within cells, and hence in GSH dependent transport processes of xenobiotics. Many airborne compounds are hazardous inducing inflammatory reactions in lung and are suspected to play a substantial role in initiation and/or promotion of tumor formation. It is interesting to clarify whether and how anti-prostaglandins modify MRP function in normal human lung cells. Aspirin, an acetylated salicylate, is classified among the non-steroidal anti-inflammatory drugs (NSAIDs), reduce inflammatory signs and symptoms exhibiting a broad range of pharmacological activities (analgesic, antipyretic and antiplatelet properties). Cyclooxygenase (COX)-system catalyses the rate limiting step in prostanoids (prostaglandin (PG)) synthesis and is also involved in drug resistance and poor prognosis of many neoplastic diseases. Aspirin's ability to suppress prostaglandins and thromboxanes production is due to its irreversible inactivation of the cyclo-oxygenase (COX) enzyme. Furthermore, transport activity study of MRP1 in NHBEC, PLC and A549 under the effect of exogenously supplied PGE2 showed an increased activity. METHODOLOGY and RESULTS: In this study, both the localisation and description of the cellular distribution of MRP-1 under standard culture conditions in normal human bronchial epithelial cells (NHBEC), peripheral lung cells (PLC) and tumor lung cells (A549) was proved using indirect immunofluorescence microscopy. All substrates and incubation periods have been prechecked for cellular toxicity in the MTT assay in order to guarantee that non toxic conditions are applied. CONCLUSION: COX inhibitor (acetylsalicylic acid 1,2mM) could significantly decrease the transport activity of MRP1 in NHBEC, PLC and A549 in 1 and 3 days trials.
INTRODUCTION

Multidrug
Resistance-Related Proteins (MRPs) are genetically related trans-membrane proteins where some are functionally uncharacterized while many are shown to mediate an ATP linkedefflux of organic anions from cells contrary to concentration gradient Of this subfamily, MRP1-6 are the best investigated members. MPR1 plays an important physiological role in protecting certain tissues from chemotherapeutic effects as well as in inflammatory reactions and antigenpresenting "dendritic" cell function. MRP2 is incorporated in hepatobiliary clearance of conjugated bilirubin. MRP3 confers resistance to epipodophyllotoxins and acts as a part in the pathologic disposition of bile acids. Glutathion-, glucuronate-or sulfate-conjugates of lipophilic compounds are physiological substrates of MRP1-3. MRP1-4pumps representeffective resistance factors for diverse chemotherapeutic drugse.g. methotrexate, and MRP1 may be involved in maintaining folate homeostasis. MRP4, 5 and 8 are cellular efflux pumps that provide resistance to nucleotide analogs. MRP6 transports, not only glutathione conjugates, but also is a broad-spectrum porphyrin transporter.MRP9has structural similarity to MRP4, 5 and 8, so that the possibility of sharing some of the properties of the latter is raised. Therefore, mammalian MRPs may help in protecting their host cells against toxic substances especially lung cells, not only because it is a target organ for many air borne toxic xenobiotics but also as a portal of entry for inhaled toxins ( Environmental pollutants have been found to intiate inflammatory responsein pulmonary mucosa. Prostaglandins (PGs) are biologically active lipid-derived autacoids synthesized through a sequential enzymatic metabolism of arachidonic acid. Structurally different PGsare described as potent (pro)inflammatory mediators. Cyclooxygenase (COX)system is the catalyst of the rate limiting step in PG synthesis (clinically characterised as target for the action of non-steroidal anti-inflammatory drugs (NSAIDs)). Studies also showed a definite association between COXsystem and malignancy with augmented PG production as well as its involvement in endogenous regulation of mdr1 gene. PGF2 and PGE2 stimulated the in-vitro expression of the ABC transport protein Pgp (mdr1b) in rat hepatocytes in culture, and the COX-system inhibitors modulate the transport activity of this protein. 
MATERIAL AND METHODS
Donors
Specimen donors were tumor patients who underwent operative interventions at the Hospital of Halle University. Age, drug intake and smoking were not considered exclusion criteria. Written consents that tissue specimens can be used for cell culture purposes were signed whichwas approved by the ethical committee of Halle-Wittenberg University.The study did not interfere with the medical management at any time.
Antibodies
 Primary rabbit polyclonal antibodies were raised against a recombinant protein corresponding to amino acids 1-70 mapping at the amine terminus of MRP1 of human origin.

Secondar y antibodies, labeled with FITC.
Both primary and secondary antibodies were purchased from Santa Cruz Biotech. Inc. (Santa Cruz, USA)
In-vitro culture of Normal Human Bronchial Epithelial Cells (NHBEC) from bronchial tissue
 Normal tissue specimens were obtained from resected lung, proximal to the tumor. They were then immersed immediately into cold sterile buffer solution (Leibovitz L15-buffer; Biochrom, Berlin, Germany).

Bronchial tissue was separated from the surrounding lung and cut into small pieces which were placed onto fibronectin-, collagen-and Bovine-Serum-Albumin pre-coated culture dishes containing L15-medium (Seromed, Berlin, Germany).
Five minutes later, serumfree medium SFM (AECG-medium, PromoCell, Heidelberg, Germany) was applied.
 Over 2-3 weeks, cells grew out of the cultivated bronchial tissue pieces and became adherent to the upper surface of the coated culture dishes, until subtotal confluence (80-90%) was reached (first generation).
 Culture medium was renewed every 48hours.
 Tested cells were mainly from the first generation.
In-vitro culture of normal peripheral lung cells
 Lung tissue distal to the bronchial tree was examined microscopically and proved to be free of bronchial epithelial cells.
 Normal peripheral lung tissue was resected and preserved directly in cold buffer (L15 Leibovitz buffer; Biochrom, Berlin, Germany).
 Pieces from the resected normal lung tissue were transferred onto uncoated culture dish (Techno Plastic Products TPP).
 Cultured tissues were maintained in serum-free AECG medium (PromoCell, Heidelberg, and Germany).
 Cell grew out and formed a subconfluent cell monolayer within 4-5weeks.
Culture of lung tumor cells  A549 human lung cell line; a lung adenocarcinoma cell line with morphological AII cell characteristics;
was used in this study.
 Cells were generously provided by Dr. F. Wiebel, Munich.
 All lung cancer cells were cultured in tissue culture flasks (Techno Plastic Products TPP, Trasadingen, Switzerland) in DMEM medium (Gibco, Berlin), supplemented with 10% fetal calf serum (c.c. pro, Neustadt/W., Germany) and 1% penicillin/streptomycine (10000IE/ml).
 Medium was changed every 2-3 days.
2.6. Viability assay  Cell viability and non-lethal concentrations of used chemicals were assesed by the colorimetric MTT assay.
 Briefly, the principle of the test depends on enzymatic conversion of substrate(MTT-reagent)into chromogenic product (formazan)by cellular dehydrogenases with color change from yellow to blue in live cells.
Cell Treatment with the PG-COX pathway modulator and CDF transport-Assay
 The fluorescence dye 5,6carboxy-2`-7`-dichlorofluorescein (CDF) is a specific MRP1 substrate that was engaged in a single cell functional assay of adherent cells for testing the transmembranous transport properties of MRP1 (Stehfest et al., 2005).
 COX-enzyme inhibitor (acetylated salicylate-1,2mM-Sigma) was added to the cultivated adherent NHBEC, PLC and A549 cells for 24 and 72hrs.
 Cells were then incubated with the MRP substrate CDF (4µg/ml) at 37°C for 4hrs.
 Then, the cells were washed with buffer solution (PBS)after removing the medium containing the fluroscence substrate CDF.
 For imaging and measuring intracellular content of CDF, the chamber slides were examined by an inverted microscope (Nikon Diaphot AFX-DX).
 Lung cells burdened with CDF were excited by UV light of 460nm.
 Emitted fluorescence signal passed through a 490nm emission filter and was registered by a photomultiplier tube.
 DSCAN soft ware (Amko Ltd) was used for the fluorescence excitation adjustment sowie data processing.
2.8.
Interpretation of the performed experiments  Presented data are results of at least three independent experiments.
 All data were expressed as mean±standard error (SE).
 Comparisons and statistical significance were performedusing ttest.
RESULTS
Primary Human Lung Cell Cultures
Histologically, normal lung resections were used as raw material to obtain serum free cultures of human lung cells i.e. a Normal Human Bronchial Epithelial Cell culture (NHBEC) from the proximal bronchial tree and a Peripheral Lung Cell culture (PLC) from distal parts of the human lung. These cultures were previously characterised as cultures of lung epithelial cells by immunocytochemistry. Outgrowth mono-layers from tissue material (generations) were taken as the main experimental skeleton in order to maintain a close resemblance to the tissue material.
Immuno-localization of MRP1
 Localization of MRP1 was analysed by indirect immunofluorescent staining.
 Methanol fixed cells were immune-stained with MRP1 antibodies after conduction of permobilization and non-specific blocking steps.
 MRP1 was localised in the cell membrane of all examined cells (figure 1).
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Fluorescence imaging to monitor the effect of PG-COX system-related modulator on MRP1 transport function.
It has been proved that cellular distribution of MRP isoforms is not unique in both normal human lung cells and A549 lung tumor cells measured by immunofluorescence.
Furthermore, substantial differences in the basic expression of MRP isoforms between these lung cells were observed. A549 cells exhibited a higher mRNA level for MRP1, 3 and 4 than NHBECs and PLCs. On the other hand, in A549 MRP5, mRNA was lower than the level in normal lung cells. NHBECs and PLC had a very similar pattern of mRNA expression for these MRP is forms (Torky et al, 2008) .
To translate MRP expression at both mRNA and protein levels to an observed functional event, a functional assay was designed to quantify MRP1 activity by the extrusion of fluorescence marker 5,6-carboxy-2'7'dichorofluorescein (CDF). For this purpose, attached cells were measured in non-cell destructive micro-method of fluorecence imaging where only a few number of attached cultured cells are For testing the potential modulatory influence of inflammatory mediators on MRP1-dependent CDF-transport NHBEC, PLC and A549 cell cultures pre-incubated with COX-enzyme inhibitor (acetylated salicylate) have been undertaken for experimental purposes. Lung cells were set onto precoated borosilicate cover glasses. Cells were incubated with acetylated salicylate (1mM, 2mM) for 24 or 72hrs. Efflux kinetics of CDF (transport activity of MRP1), were substantially reduced in all tested cells (figures2, 3 and 4). Cytotoxicity of test substrates has been pre-testedusing MTT assay to determine nontoxic concentrations (table 1) . 
DISCUSSION
Inhalation is a very common route of exposure to many toxic xenobiotics; therefore, the respiratory tract is considered a target organ for their potential toxic effects. Lung-directed studies using human based material represent an important step to uncover mechanisms of many toxicopathological changes in the lung even on the cellular level. A substantial morphological redifferentiation of rodent, canine and human tracheal epithelial cells was reported for culture systems using airliquid interfaces that mimic physiological lung conditions. Johnson and colleagues, (1993) reported an enhanced sodium transport and aerobic pattern of metabolism in canine bronchial epithelial cells cultured invivo-like air-liquid conditions in contrast to controls cultivated under conventional conditions. Rat alveolar type II cells are promoted to express differentiated type II cell characteristics (lamellar bodies, tubular myelin) and biochemical functions (phosphatidylcholine secretion) (Khosa Cells from both lung topographic regions responded to changes in culture conditions such as applications of the dry-wet configuration of cell culture. Cells regain a polarized nature and acquire a highly differentiated physiological shape. Mixed cell type culture from peripheral lung establishes "alveoli-like" structures that are of concern which can only occur when apoptosis and anti-apoptosis are active and are still controlled by a meaningful battery of regulating factors.
Regulation of MRPs is still unknown and their expression is not a fast event in the lung. Variation within the material from a single individual is astonishingly low and stressors from the side of ROS generation, toxic metals and inflammatory mediators have a relatively low impact compared to what is known for liver and for regulation of MDRs. Furthermore, inducers of xenobiotic metabolizing enzymes that appears to increase intracellular levels of metabolites affect transporter expression responsible for metabolite export. Alteration of functional activity of transporters might influence both kinetics and effects of inhaled toxins (Nagayoshi et al., 2004;  Hao et al., 2019) .
Therefore, MRPs expression and localization in lung cells under both classic and dry-wet culture conditions were investigated and for these purposes, cultures of NHBEC, PLC and A549 were used as a test tool. Vol 19 (4) , Dec 2019 location is not well understood (Haimeur et al., 2004) .
Several different function assay systems measuring accumulation and efflux of radio-labelled or fluorescent xenobiotics have been useful not only for identifying substrates of MRP1 but also for studying the relative MRP1 transport activity in intact cells (Haimeur et al., 2004) . Lehmann and other researchers, (2001) confirmed an expression of immune-reactive MRP1 protein in cultured human lung cells.
Messenger RNA expression gives an idea about protein regulation in pretranslational stages but is not enough for functional characterization. This problem could not be overcome by Classical Western blotting for MRPs. Therefore, a non-destructive quantitative fluorescence microscopy assay for functional characterization of MRP1-mediated transport was established across lung epithelium. This micro-method represents a promising analytical tool to understand mRNA transformation into functionally active protein (Stehfest et al., 2005) .
The MRP1 activityis closely related to cellular glutathion content and is involved in GSH-dependent xenobiotictransport (Borst et al., 2000; Gana et  al., 2019) .
To check both the sensitivity and specificity of the assay, glutathione pool in tumor cell lines A549, H358 and H322was manipulated by an inhibitor, buthionine sulfoximine (BSO), and a promoter, N-acetyl cystein (NAC) of the glutathione synthesis. BSO reduced MRP1 transport activity through inhibition of glutathione synthesis. NAC pre-incubated cells exhibited anenhanced MRP1-mediated transport due to increased cellular glutathion levels (Stehfest et al, 2007) .
Physiological function of MRP1 comprises secretion of prostaglandin (PGA2) and leukotrienes (LTC4, LTD4, LTE4), efflux of glutathione disulfide as well as transport of organic anions and other substances conjugated to glutathione, glucuronide, or sulphate (Jedlitschky et al., 1996; Renes et al.,  2000; Hao et al, 2019) .
Data clearly show that bronchial and peripheral lung cells react differently towards prostaglandins. Bronchial cells react while peripheral lung cells and lung tumor cells don't and PGE2 is active while PGF2 is inactive. MRP1, 3 and 5 are upregulated by PGE2 which was applied in non toxic concentrations; an effect that needs time to develop. Taken together, it must be expected that inflammatory mediators are modulators for MRP expression (Torky et al.,  2008) .
This study demonstrated that acetyl salicylic acid might modify MRP1 activity in human lung cells. It could suppress MRP1-mediated efflux transport in bronchial epithelial cells, PLC as well as A549 tumor cells.Together, cell membrane situation of MRP1 used as a test tool adds to cellular ability to withstand opposing environmental factors and may also be the trigger zone for chemotherapeutic resistance in tumor cells through rapid extrusion of such agents via the membrane situated protein pumps. Therefore, an enhanced therapeutic scope to develop a potent reverser of drug resistance may be introduced by 
